Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IPOs
IPOs
Gosssamer Bio to Use 20 Day Rule for $230 Million IPO
Wed, 01/23/19 - 09:14 pm
Gossamer Bio
IPOs
Gossamer sets fixed share price for $230M IPO to sidestep shutdown
BioCentury
Wed, 01/23/19 - 08:14 pm
Gossamer Bio
IPOs
government shutdown
Microbiome Report for Week Ending 1/19/19
CP Wire
Wed, 01/23/19 - 09:35 am
microbiome
Seres Therapeutics
Synlogic
Kaleido Biosciences
IPOs
Amid Government Shutdown, Companies Try New Approaches to IPOs
BioSpace
Tue, 01/22/19 - 12:19 am
IPOs
government shutdown
As shutdown stalls IPOs, companies mull creative paths to market
Biopharma Dive
Fri, 01/18/19 - 09:13 pm
SEC
NASDAQ
IPOs
Alzheon hits another dead end funding its Alzheimer's program, pulls second IPO attempt
Endpoints
Thu, 01/17/19 - 09:42 am
Alzheon
IPOs
clinical trials
ALZ-801
Alzheimer's disease
Brainsway registers for $30m IPO
Mass Device
Wed, 01/16/19 - 11:51 pm
Brainsway
IPOs
devices
Deep Transcranial Magnetic Stimulation
After JPM, biotechs still scrambling for IPOs as Kaleido, Cirius file amid government shutdown
Fierce Biotech
Mon, 01/14/19 - 11:35 am
IPOs
Kaleido Biosciences
Cirius Therapeutics
NASDAQ
JPMHC 2019
government shutdown
Kaleido Bio and Cirius Join an IPO Queue Stalled by Federal Shutdown
Xconomy
Fri, 01/11/19 - 08:14 pm
IPOs
government shutdown
Kaleido Biosciences
Cirius Therapeutics
JPM recap: Must-reads of the week, from FDA to IPO to M&A and more
Fierce Pharma
Fri, 01/11/19 - 10:25 am
JPMHC 2019
Merck
FDA
M&A
Celgene
Bristol-Myers Squibb
Genevant
IPOs
Eli Lilly
Novartis
GSK
Teva Pharmaceutical
Alexion
Pear Therapeutics
Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs
Xconomy
Tue, 01/8/19 - 09:19 am
IPOs
Alector
Alzheimer's disease
dementia
Poseida pitches a $115M IPO on its claim that the science team has created a better BCMA CAR-T
Endpoints
Sun, 01/6/19 - 01:58 pm
Poseida Therapeutics
IPOs
BCMA
CAR-T
The Week Ahead In Biotech: Conferences, Clinical Trials
Yahoo/Benzinga
Sun, 01/6/19 - 01:55 pm
JPMHC 2019
Axsome Therapeutics
Miragen Therapeutics
Aptorum Group
IPOs
Poseida Therapeutics Prepares for IPO to Advance CAR-T Treatments
Xconomy
Sat, 01/5/19 - 12:11 am
Poseida Therapeutics
CAR-T
IPOs
solid tumors
Pharma's 2019 Prognosis Hinges on These Key Themes
Bloomberg
Wed, 01/2/19 - 09:48 pm
drug pricing
Amarin
Vascepa
IPOs
cancer
TCR2 Shoots for $100 Million IPO in Early 2019
BioSpace
Wed, 01/2/19 - 11:41 am
TCR2 Therapeutics
IPOs
CAR-T
Did Moderna break the biotech IPO market?
Endpoints
Wed, 01/2/19 - 11:17 am
Moderna Therapeutics
IPOs
At the Eleventh Hour, Harpoon Therapeutics Signs up to Join the 2018 IPO Game
BioSpace
Fri, 12/28/18 - 01:11 pm
Harpoon Therapeutics
IPOs
tech
A Record Year: A Look at the Biotech IPOs for Q4 2018
BioSpace
Fri, 12/28/18 - 12:57 pm
IPOs
biotech
Moderna Therapeutics
Allogene
Rubius Therapeutics
Kodiak Sciences
Guardant Health
SI Bone
Gossamer Bio Plans to Raise $264.5 Million with IPO
BioSpace
Wed, 12/26/18 - 04:34 pm
Gossamer Bio
IPOs
Pages
« first
‹ previous
…
24
25
26
27
28
29
30
31
32
…
next ›
last »